Deep and Durable Responses with Selinexor, Daratumumab, and Dexamethasome(SDd) in Patients with Multiple Myeloma Previously Treated with PIs and IMiDs: Results of Phase 1b/2 Study of SDd
Deep and Durable Responses with Selinexor, Daratumumab, and Dexamethasome(SDd) in Patients with Multiple Myeloma Previously Treated with PIs and IMiDs: Results of Phase 1b/2 Study of SDd